Gland Pharma Limited (GLAND) — Cash Flow Reinvestment Rate
Gland Pharma Limited (GLAND) has a Cash Flow Reinvestment Rate of 0.33x as of September 2025, reinvesting Rs1.94 Billion (capex Rs1.94 Billion ) from operating cash flow of Rs5.93 Billion. Explore GLAND capex reinvestment rate to see what proportion of operating cash flow is directed to capital expenditures.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Gland Pharma Limited Cash Flow Reinvestment Rate (2017–2025)
Historical reinvestment intensity for Gland Pharma Limited across 9 annual periods. Also explore GLAND total assets for the complete picture of this company's asset base.
Annual Cash Flow Reinvestment Rate for Gland Pharma Limited (2017–2025)
Year-by-year capital reinvestment analysis for Gland Pharma Limited. For live market cap and broader valuation context, see how much is Gland Pharma Limited worth.
| Year | Reinvestment Rate | Total Reinvested (INR) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 2.28x | Rs20.89 Billion | Rs9.15 Billion | Rs3.85 Billion | ▲ +6.0% |
| 2024 | 2.15x | Rs21.47 Billion | Rs9.97 Billion | Rs3.90 Billion | ▼ -45.2% |
| 2023 | 3.93x | Rs14.31 Billion | Rs3.64 Billion | Rs2.23 Billion | ▲ +174.3% |
| 2022 | 1.43x | Rs11.34 Billion | Rs7.91 Billion | Rs5.22 Billion | ▼ -45.3% |
| 2021 | 2.62x | Rs15.86 Billion | Rs6.05 Billion | Rs2.29 Billion | ▲ +120.6% |
| 2020 | 1.19x | Rs8.33 Billion | Rs7.01 Billion | Rs1.95 Billion | ▼ -37.9% |
| 2019 | 1.91x | Rs3.54 Billion | Rs1.85 Billion | Rs1.36 Billion | ▲ +0.9% |
| 2018 | 1.90x | Rs3.83 Billion | Rs2.02 Billion | Rs851.75 Million | ▲ +118.1% |
| 2017 | 0.87x | Rs4.14 Billion | Rs4.76 Billion | Rs1.16 Billion | — |